Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform.
Enja Tatjana KipferDavid HauserMartin J LettFabian OtteLorena UrdaYuepeng ZhangChristopher M R LangMohamed ChamiChristian MittelholzerThomas KlimkaitPublished in: bioRxiv : the preprint server for biology (2023)
Reverse genetic systems enable engineering of RNA virus genomes and are instrumental to study RNA virus biology. With the recent outbreak of the COVID-19 pandemic, already established methods were challenged by the large genome of SARS-CoV-2. Herein we present an elaborated strategy for the rapid and straightforward rescue of recombinant plus-stranded RNA-viruses with high sequence fidelity, using the example of SARS-CoV-2. The strategy called CLEVER (CLoning-free and Exchangeable system for Virus Engineering and Rescue) is based on the intracellular recombination of transfected overlapping DNA fragments allowing the direct mutagenesis within the initial PCR-amplification step. Furthermore, by introducing a linker fragment - harboring all heterologous sequences - viral RNA can directly serve as template for manipulation and rescue of recombinant mutant virus, without any cloning-step needed. Overall, this strategy will facilitate recombinant SARS-CoV-2 rescue and accelerate its manipulation. Using our protocol, newly emerging variants can quickly be engineered to further elucidate its biology.
Keyphrases
- sars cov
- nucleic acid
- respiratory syndrome coronavirus
- copy number
- cell free
- crispr cas
- genome wide
- randomized controlled trial
- disease virus
- gene expression
- oxidative stress
- circulating tumor
- reactive oxygen species
- dna damage
- high throughput
- binding protein
- loop mediated isothermal amplification
- genetic diversity
- dna repair
- circulating tumor cells
- liquid chromatography